Overview

A First Time in Human Study in Healthy Volunteers and Patients

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
A multi-part study to investigate the safety, tolerability and local and systemic pharmacokinetics of V565
Phase:
Phase 1
Details
Lead Sponsor:
VHsquared Ltd.